▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Accessibility Log In Help

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Helix BioPharma (OTC: HBPCF)

$0.60

(1.7%)

$0.01

Price as of May 19, 2025, 1:57 p.m. ET

Helix BioPharma Return vs. S&P

	1 Year	5 Year	5 Year Annualized	Since IPO
HBPCF	-22.63%	-68.58%	-20.63%	-96%
S&P	+16.09%	+90.36%	+13.72%	+463%

Helix BioPharma Company Info

Helix BioPharma Corp. is an immuno-oncology company, which engages in the development of products for the treatment and prevention of cancer. The company was founded on July 31, 1995 and is headquartered in Toronto, Canada.

News & Analysis

No articles found.

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services